Arkolith/Insider Trading/ZOM/Form 4

Klass Russell Kevin

Sr Vice President of SalesZomedica Corp. (ZOM) · full profile →Form 4 · filed Mar 18, 2025
Net Buying
Open-Market Buys
$49K
Open-Market Sells
$0
Net Open-Market Flow
$49K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2025Buy(P)700K$0.07$49K3.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-25-002954) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML